The main diagnostic basis for aplastic anemia

Written by Peng Miao Yun
Internal Medicine
Updated on September 27, 2024
00:00
00:00

Aplastic anemia is caused by a variety of reasons leading to bone marrow hematopoietic failure. So, what is the main diagnostic basis for diagnosing aplastic anemia? It is primarily the bone marrow examination, which shows decreased or severely decreased proliferation at least in one site, such as active proliferation, significant reduction in megakaryocytes, and an increase in non-hematopoietic cells in the bone marrow's granular components. Additionally, there can be a decrease in total blood cells, white cells, red cells, etc., and a reduction in the absolute value of reticulocytes.

Other Voices

doctor image
home-news-image
Written by Li Fang Fang
Hematology
52sec home-news-image

How long can one live with aplastic anemia?

The lifespan of patients with aplastic anemia depends on the type and the effectiveness of the treatment. Aplastic anemia is classified into acute aplastic anemia and chronic aplastic anemia. In cases of acute aplastic anemia, cure is possible through intensified immunotherapy or hematopoietic stem cell transplantation; however, without aggressive treatment, the survival period is relatively short, generally not exceeding one year. Chronic aplastic anemia, on the other hand, has a longer medical history, and patients can often live for ten to twenty years or more. However, throughout this period, ongoing transfusions of red blood cells and platelets are required to support treatment.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
39sec home-news-image

Aplastic anemia is caused by how?

Aplastic anemia currently still has an uncertain etiology. However, clinical observations have suggested that chemotherapy drugs, viral infections, and radiation exposure might be related to the occurrence and development of aplastic anemia. Regardless of the cause, these factors all involve abnormalities in immune function. Abnormal immune function leads to the occurrence and development of aplastic anemia. Therefore, immunosuppressive therapy is often effective for patients with aplastic anemia in clinical settings. (Medication use should be conducted under the guidance of a professional doctor.)

doctor image
home-news-image
Written by Li Fang Fang
Hematology
56sec home-news-image

Can aplastic anemia be cured?

Aplastic anemia is divided into acute aplastic anemia and chronic aplastic anemia. Acute aplastic anemia can be cured by intensive immunotherapy or syngeneic hematopoietic stem cell transplantation. However, not all cases of acute aplastic anemia can be cured by these two treatments, with the cure rate being approximately 60%-70%. For chronic aplastic anemia, the main treatment currently is oral immunosuppressive therapy, which usually cannot cure the condition unless allogeneic hematopoietic stem cell transplantation is performed. However, if patients with chronic aplastic anemia are on oral immunosuppressive therapy, they can maintain a relatively good condition and typically do not opt for allogeneic hematopoietic stem cell transplantation.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
45sec home-news-image

What causes aplastic anemia?

Aplastic anemia's exact causes are still not completely clear. Clinically, it is believed that immune dysfunction is a significant factor associated with aplastic anemia. Most cases of aplastic anemia can achieve good therapeutic outcomes through immunosuppressive treatment, which indirectly supports this view. However, some scholars believe that in aplastic anemia, there are patients for whom immunosuppressive treatment is ineffective. This suggests that other factors might exist, such as congenital anomalies in hematopoietic stem and progenitor cells, or abnormalities in the hematopoietic microenvironment, which may also play a role in the development of aplastic anemia.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
49sec home-news-image

The main cause of aplastic anemia is.

The causes of aplastic anemia are considered to be of three types: abnormalities in hematopoietic stem cells, abnormalities in the bone marrow microenvironment, and abnormalities in immune factors. Among these, abnormalities in immune factors play a dominant role. Therefore, most patients with aplastic anemia see some improvement after receiving immunosuppressive therapy clinically. However, there is a small subset of patients with aplastic anemia for whom immunosuppressive therapy is not effective, and the causes of the disease in these patients are not well understood and may be congenital, such as congenital dyskeratosis.